Carolinas Wealth Consulting’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59
| Closed | -$28.6K | – | 937 |
|
|
2025
Q1 | $28.6K | Buy |
59
+3
| +5% | +$1.45K | 0.01% | 411 |
|
|
2024
Q4 | $22.6K | Hold |
56
| – | – | ﹤0.01% | 458 |
|
|
2024
Q3 | $26K | Sell |
56
-1
| -2% | -$465 | ﹤0.01% | 449 |
|
|
2024
Q2 | $26.7K | Sell |
57
-56
| -50% | -$26.2K | 0.01% | 447 |
|
|
2024
Q1 | $47.2K | Sell |
113
-148
| -57% | -$61.9K | 0.01% | 384 |
|
|
2023
Q4 | $106K | Buy |
261
+56
| +27% | +$22.8K | 0.02% | 226 |
|
|
2023
Q3 | $74.2K | Sell |
205
-101
| -33% | -$36.6K | 0.02% | 257 |
|
|
2023
Q2 | $108K | Buy |
306
+75
| +32% | +$26.4K | 0.02% | 250 |
|
|
2023
Q1 | $72.8K | Buy |
231
+64
| +38% | +$20.2K | 0.02% | 304 |
|
|
2022
Q4 | $48.2K | Sell |
167
-17
| -9% | -$4.91K | 0.01% | 367 |
|
|
2022
Q3 | $53K | Sell |
184
-18
| -9% | -$5.19K | 0.01% | 318 |
|
|
2022
Q2 | $57K | Sell |
202
-49
| -20% | -$13.8K | 0.01% | 309 |
|
|
2022
Q1 | $66K | Sell |
251
-59
| -19% | -$15.5K | 0.01% | 315 |
|
|
2021
Q4 | $68K | Hold |
310
| – | – | 0.01% | 318 |
|
|
2021
Q3 | $56K | Hold |
310
| – | – | 0.01% | 328 |
|
|
2021
Q2 | $63K | Hold |
310
| – | – | 0.01% | 331 |
|
|
2021
Q1 | $67K | Buy |
310
+42
| +16% | +$9.08K | 0.02% | 320 |
|
|
2020
Q4 | $63K | Buy |
268
+131
| +96% | +$30.8K | 0.02% | 301 |
|
|
2020
Q3 | $37K | Buy |
137
+59
| +76% | +$15.9K | 0.01% | 320 |
|
|
2020
Q2 | $23K | Buy |
+78
| New | +$23K | 0.01% | 275 |
|